bpc-157 fda warning not approved for human use FDA's Overreach on Compounded Peptides A closer look at the
Description
Walsh, Sarah K., et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 51.Nigwekar S.U., Kang A., Zoungas S., et al
Lipotropic injections are often marketed by weight loss clinics as treatments that promote fat burning
GLP-1 receptor agonism is associated in the research literature with modulation of satiety signaling and energy expenditure, underpinning much of the weight reduction focus in Retatrutide study designs

B12 does not burn fat directly

The compound also attenuated hepatic steatosis (fatty liver) and improved liver enzyme markers